Scleroderma is associated with differences in individual routes of drug metabolism: A study with dapsone, debrisoquin, and mephenytoin

D. Gail May, Carol M. Black, Nancy J. Olsen, Mary E. Csuka, S. Bobo Tanner, Lisa Bellino, James A. Porter, Grant R. Wilkinson, Robert A. Branch

Research output: Contribution to journalArticle

38 Scopus citations

Abstract

Exposure to certain environmental agents may induce a scleroderma-like syndrome in a small proportion of individuals. Differences in susceptibility could involve metabolic activation of a protoxin, with affected patients having a greater converting ability. This possibility was investigated in 84 patients with scleroderma and 108 control subjects with in vivo probes of specific pathways of metabolism. Scleroderma was associated with reduced hydroxylating activity for dapsone and S-mephenytoin, whereas the ability to hydroxylate debrisoquin and N-acetyl dapsone was similar in both groups. Logistic regression confirmed these associations based on the shift in frequency distribution. Individuals who were poor metabolizers for mephenytoin and only modest N-hydroxylators of dapsone had a tenfold increased risk of scleroderma (p = 0.008). Thus this combined metabolic impairment may be causally involved in the development of scleroderma or, alternatively, the disease may produce inhibition of selected metabolizing enzymes in a subset of patients.

Original languageEnglish (US)
Pages (from-to)286-295
Number of pages10
JournalClinical pharmacology and therapeutics
Volume48
Issue number3
DOIs
StatePublished - Sep 1990

All Science Journal Classification (ASJC) codes

  • Pharmacology
  • Pharmacology (medical)

Fingerprint Dive into the research topics of 'Scleroderma is associated with differences in individual routes of drug metabolism: A study with dapsone, debrisoquin, and mephenytoin'. Together they form a unique fingerprint.

  • Cite this

    Gail May, D., Black, C. M., Olsen, N. J., Csuka, M. E., Bobo Tanner, S., Bellino, L., Porter, J. A., Wilkinson, G. R., & Branch, R. A. (1990). Scleroderma is associated with differences in individual routes of drug metabolism: A study with dapsone, debrisoquin, and mephenytoin. Clinical pharmacology and therapeutics, 48(3), 286-295. https://doi.org/10.1038/clpt.1990.151